Group One Trading’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5
Closed -$87 7615
2024
Q4
$87 Sell
5
-95
-95% -$1.62K ﹤0.01% 7110
2024
Q3
$2.72K Sell
100
-75
-43% -$2.33K ﹤0.01% 6067
2024
Q2
$7.12K Sell
175
-115
-40% -$6.32K ﹤0.01% 5793
2024
Q1
$19.3K Sell
290
-1,042
-78% -$77.8K ﹤0.01% 5436
2023
Q4
$151K Sell
1,332
-58
-4% -$6.06K ﹤0.01% 4117
2023
Q3
$253K Buy
1,390
+1,280
+1,164% +$335K ﹤0.01% 3599
2023
Q2
$40.3K Sell
110
-12
-10% -$5.42K ﹤0.01% 5442
2023
Q1
$81.5K Sell
122
-184
-60% -$163K ﹤0.01% 4473
2022
Q4
$268K Buy
306
+85
+38% +$107K ﹤0.01% 3602
2022
Q3
$243K Buy
221
+136
+160% +$180K ﹤0.01% 3948
2022
Q2
$71K Sell
85
-29
-25% -$29.8K ﹤0.01% 5275
2022
Q1
$176K Sell
114
-121
-51% -$163K ﹤0.01% 4929
2021
Q4
$422K Sell
235
-141
-38% -$377K ﹤0.01% 4327
2021
Q3
$1.24M Sell
376
-492
-57% -$1.72M ﹤0.01% 3179
2021
Q2
$3.82M Buy
868
+166
+24% +$655K ﹤0.01% 1962
2021
Q1
$3.4M Buy
+702
New +$3.96M 0.01% 1902

Other funds holding BNGO

Group One Trading's BNGO Position: Q1 2026 in Review

Group One Trading reduced its Bionano Genomics (BNGO) stake by 27% in Q1 2026, selling an estimated $455 and leaving 957 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #7199.

Group One Trading first reported a position in BNGO in Q2 2021 and has held it in 17 quarters since. The position peaked at $2M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Group One Trading held 957 shares of Bionano Genomics worth $1.12K as of Q1 2026.
  • Group One Trading sold 355 Bionano Genomics shares in Q1 2026, an estimated $455.
  • Bionano Genomics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7199 holding.
  • Group One Trading first reported a position in Bionano Genomics in Q2 2021 and has held it in 17 quarters since.
  • Group One Trading's Bionano Genomics position peaked at $2M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.